Immunization with a lentivector that targets tumor antigen expression to dendritic cells induces potent CD8+ and CD4+ T-cell responses. par Lopes, L, Dewannieux, M, Gileadi, U, Bailey, R, Ikeda, Y, Whittaker, C, Collin, M, Cerundolo, V, Tomihari, M, Ariizumi, K, Collins, M